1,2-dipalmitoylphosphatidylcholine has been researched along with Respiratory Distress Syndrome in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agudelo, CW; Garcia-Arcos, I; Samaha, G | 1 |
| Krafft, MP; Lee, S; Nakahara, H; Shibata, O | 1 |
| Mittal, N; Sanyal, SN | 1 |
| Notter, RH; Willson, DF | 1 |
| Jackson, SK; Jones, KP; Morris, RH; Tonks, A; Tonks, AJ | 1 |
| Albrecht, TB; Ballinger, CA; Connor, LM; Postlethwait, EM | 1 |
| Banerjee, RR | 1 |
| Baudouin, SV | 1 |
| Moen, MD; Perry, CM; Wellington, K | 1 |
| Lewis, JF; Maruscak, A | 1 |
| Baritussio, A; Carnielli, VP; Chierici, M; Cobelli, C; Cogo, PE; Gucciardi, A; Ori, C; Toffolo, GM; Vianello, A | 1 |
| Amrein, M; Baoukina, S; Doehner, J; Eng, LM; Felderer, F; Gill, S; Gunasekara, L; Leonenko, Z; Monticelli, L; Rodenstein, M | 1 |
| Macrae, D; Nichani, SH; Novelli, V; Slater, AJ; Tasker, RC; Wilkinson, KA | 1 |
| Ito, M; Otake, K; Saito, Y; Suwabe, A; Suzuki, H; Takahashi, K; Tomoike, H; Yakuwa, N | 1 |
| Arbibe, L; Touqui, L | 1 |
| Kobayashi, T; Matsumoto, Y; Nishizuka, K; Ohta, K; Suzuki, Y; Tashiro, K | 1 |
| Barton, TL; Chan, CY; Rasch, DK | 1 |
| Burke, JF; Gelfand, JA; Hales, CA; Li, JJ; McAdam, KP; Sanders, RL; Thompson, BT | 1 |
| Joka, T; Kirschfink, M; Obertacke, U; Schmit-Neuerburg, KP; Zilow, G | 1 |
| Notter, RH | 1 |
6 review(s) available for 1,2-dipalmitoylphosphatidylcholine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Alveolar lipids in pulmonary disease. A review.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Humans; Lipid Metabolism; Lung; Lung Diseases; Macrophages, Alveolar; Pulmonary Alveoli; Pulmonary Surfactants; Respiratory Distress Syndrome | 2020 |
The future of exogenous surfactant therapy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Lung Injury; Animals; Extracorporeal Membrane Oxygenation; Humans; Infant, Newborn; Pulmonary Surfactants; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Newborn | 2011 |
Lucinactant: in neonatal respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intercellular Signaling Peptides and Proteins; Peptides; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension; Treatment Outcome | 2005 |
Exogenous surfactant therapy for ARDS.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Administration Routes; Drug Administration Schedule; Humans; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Recombinant Proteins; Respiratory Distress Syndrome; Survival Rate | 2006 |
Colfosceril in an infant with adult respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Female; Humans; Infant, Newborn; Pulmonary Surfactants; Respiratory Distress Syndrome | 1992 |
Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; Animals; Humans; Infant, Newborn; Lung; Pulmonary Surfactants; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Newborn | 1988 |
14 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Fluorocarbon-hybrid pulmonary surfactants for replacement therapy--a Langmuir monolayer study.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; Biocompatible Materials; Biophysics; Drug Design; Fluorocarbons; Humans; Infant, Newborn; Materials Testing; Microscopy, Atomic Force; Microscopy, Fluorescence; Peptides; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Properties | 2010 |
Surfactant blocks lipopolysaccharide signaling by inhibiting both NFκB and PARP activation in experimental ARDS.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Alveolar Epithelial Cells; Animals; Bronchoalveolar Lavage Fluid; Citrulline; Drug Combinations; Enzyme Activation; Fatty Alcohols; Hydrogen-Ion Concentration; I-kappa B Kinase; Lipopolysaccharides; Lung; Male; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Swine | 2011 |
Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetyltransferases; Acyltransferases; Cell Line; Humans; Lipopolysaccharides; Membrane Fluidity; Monocytes; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome | 2003 |
Interfacial phospholipids inhibit ozone-reactive absorption-mediated cytotoxicity in vitro.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Absorption; Air Pollutants; Animals; Cells, Cultured; Detergents; Fibroblasts; In Vitro Techniques; Male; Ozone; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Respiratory Mucosa | 2004 |
Interactions between hematological derivatives and dipalmitoyl phosphatidyl choline: implications for adult respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; Albumins; Animals; Biological Products; Blood; Blood Coagulation; Blood Platelets; Blood Proteins; Cattle; Cell Membrane; Fibrinogen; Humans; Hydrogen-Ion Concentration; Phospholipids; Respiratory Distress Syndrome; Serum; Serum Albumin; Surface Properties; Temperature | 2004 |
Exogenous surfactant replacement in ARDS--one day, someday, or never?
Topics: 1,2-Dipalmitoylphosphatidylcholine; Humans; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein B; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactants; Recombinant Proteins; Respiratory Distress Syndrome; Treatment Failure | 2004 |
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adult; Aged; Carbon Isotopes; Female; Humans; Instillation, Drug; Lung; Male; Middle Aged; Models, Biological; Pulmonary Alveoli; Pulmonary Surfactants; Respiratory Distress Syndrome; Trachea | 2007 |
An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Biophysical Phenomena; Biophysics; Cattle; Cholesterol; Humans; In Vitro Techniques; Lipid Bilayers; Lung Compliance; Microscopy, Atomic Force; Models, Molecular; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension | 2007 |
Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Humans; Infant; Male; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Surfactants; Respiratory Distress Syndrome | 1995 |
Artificial surfactant (Surfactant TA) modulates adherence and superoxide production of neutrophils.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Apoptosis; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Adhesion; Cell Nucleus; Cells, Cultured; Cricetinae; Disease Models, Animal; Endopeptidases; fas Receptor; Humans; Leukocyte Count; Liposomes; Lung; Neutrophil Activation; Neutrophils; Pneumonia; Pulmonary Alveoli; Pulmonary Surfactants; Reactive Oxygen Species; Respiratory Distress Syndrome; Superoxides | 1998 |
A role for phospholipase A2 in ARDS pathogenesis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Down-Regulation; Gene Expression Regulation; Group II Phospholipases A2; Humans; Hydrolysis; Macrophages, Alveolar; Phospholipases A; Phospholipases A2; Pulmonary Surfactants; Respiratory Distress Syndrome; Up-Regulation | 1999 |
Modified natural and synthetically reconstituted surfactant therapies for acute lung injury caused by endotoxin in rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Disease Models, Animal; Endotoxins; Escherichia coli; Follow-Up Studies; Male; Oxygen; Partial Pressure; Phosphatidylcholines; Phosphatidylglycerols; Positive-Pressure Respiration; Proteolipids; Pulmonary Surfactants; Random Allocation; Rats; Rats, Wistar; Respiratory Distress Syndrome | 1999 |
Impact of C-reactive protein (CRP) on surfactant function.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Choline; Enzyme-Linked Immunosorbent Assay; Humans; Iodine Radioisotopes; Liposomes; Phosphorylcholine; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension | 1989 |
The role of C3a in pulmonary alveoli following trauma.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anaphylatoxins; Complement C3; Complement C3a; Complement C5; Complement C5a; Granulocytes; Humans; Lung; Prospective Studies; Pulmonary Alveoli; Pulmonary Circulation; Respiratory Distress Syndrome; Shock, Traumatic | 1989 |